Common Stock, Shares, Outstanding of Lemonade, Inc. from Q4 2019 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Lemonade, Inc. quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2019 to Q3 2025.
  • Lemonade, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2025 was 74.7M shares, a 4.61% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Lemonade, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 74.7M +3.29M +4.61% Sep 30, 2025 10-Q 2025-11-05
Q2 2025 73.8M +2.82M +3.97% Jun 30, 2025 10-Q 2025-08-05
Q1 2025 73.2M +2.73M +3.88% Mar 31, 2025 10-Q 2025-05-06
Q4 2024 72.7M +2.56M +3.65% Dec 31, 2024 10-Q 2025-11-05
Q3 2024 71.4M +1.47M +2.1% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 71M +1.33M +1.92% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 70.5M +1.03M +1.48% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 70.2M +889K +1.28% Dec 31, 2023 10-K 2025-02-26
Q3 2023 69.9M +789K +1.14% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 69.7M +7.8M +12.6% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 69.4M +7.69M +12.5% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 69.3M +7.61M +12.3% Dec 31, 2022 10-K 2024-02-28
Q3 2022 69.1M +7.5M +12.2% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 61.9M +335K +0.55% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 61.8M +389K +0.63% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 61.7M +4.89M +8.61% Dec 31, 2021 10-K 2023-03-03
Q3 2021 61.6M +5.03M +8.89% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 61.5M +49.2M +397% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 61.4M Mar 31, 2021 10-Q 2021-05-12
Q4 2020 56.8M +45.5M +404% Dec 31, 2020 10-K 2022-03-01
Q3 2020 56.6M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 12.4M Jun 30, 2020 10-Q 2020-08-12
Q4 2019 11.3M Dec 31, 2019 10-K 2021-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.